Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccines: an ongoing promise?

M Alsahli1, R J Farrell, P Michetti

  • 1Department of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass., USA.

Digestive Diseases (Basel, Switzerland)
|September 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.

Alimentary pharmacology & therapeutics·2018
Same author

The gap between scientific evidence and clinical practice: 5-aminosalicylates are frequently used for the treatment of Crohn's disease.

Alimentary pharmacology & therapeutics·2014
Same author

Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines.

Alimentary pharmacology & therapeutics·2014
Same author

The management of iron deficiency in inflammatory bowel disease--an online tool developed by the RAND/UCLA appropriateness method.

Alimentary pharmacology & therapeutics·2013
Same author

Macrophages promote epithelial repair through hepatocyte growth factor secretion.

Clinical and experimental immunology·2013
Same journal

Pancreatitis in Familial Dysautonomia Patients.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Treatment outcomes with empirical Clarithromycin-based triple therapy for Helicobacter pylori in Zambia, sub-Saharan Africa.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Endoscopic submucosal dissection-associated bacteremia: proper antibiotic management.

Digestive diseases (Basel, Switzerland)·2026
Same journal

The investigation and treatment of Helicobacter pylori for the prevention of gastric cancer: A narrative review and assessment of management approaches.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Analysis of Helicobacter pylori resistance and its trends in Chongqing: A 10-year retrospective study.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Early-onset colorectal cancer in Australia: environmental, microbial, and policy implications.

Digestive diseases (Basel, Switzerland)·2026
See all related articles

Developing a vaccine for Helicobacter pylori (H. pylori) remains challenging despite extensive research. This review covers immune responses, past trials in animals and humans, and future directions for H. pylori vaccine development.

Area of Science:

  • Microbiology and Immunology
  • Vaccine Development
  • Gastroenterology

Background:

  • Helicobacter pylori (H. pylori) infection is a major cause of peptic ulcers and gastric cancer.
  • Developing an effective vaccine against H. pylori has been a significant challenge due to the organism's unique characteristics.
  • Intensive research over the past decade has focused on creating a vaccine therapy for H. pylori.

Purpose of the Study:

  • To provide an overview of current knowledge on natural and vaccine-induced immune responses to H. pylori.
  • To review past successes and failures of H. pylori vaccine candidates in animal models.
  • To discuss obstacles and future directions in H. pylori vaccine development.

Main Methods:

  • Review of existing literature on H. pylori immunology and vaccine research.

Related Experiment Videos

  • Analysis of data from animal model studies.
  • Evaluation of findings from human clinical trials on vaccine safety and immunogenicity.

    • Main Results:

    • Numerous candidate vaccines have been tested in animal models with varying outcomes.
    • Recent clinical trials have assessed the immunogenicity and safety of some H. pylori vaccine formulations.
    • The efficacy of current vaccine therapies in humans is yet to be determined.

    Conclusions:

    • Significant obstacles remain in the development of a successful H. pylori vaccine.
    • Understanding immune responses is crucial for advancing vaccine strategies.
    • Future research should focus on overcoming current challenges to achieve a viable H. pylori vaccine therapy.